C-MER Eye Care Holdings Limited (3309) Stock Statistics & Valuation Metrics

C-MER Eye Care Holdings Limited has a market cap or net worth of HK$1.52B. The enterprise value is HK$1.54B.

C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

C-MER Eye Care Holdings Limited’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.86%.

The current PE Ratio of C-MER Eye Care Holdings Limited is 20.7. C-MER Eye Care Holdings Limited’s PEG ratio is -0.12.

In the last 12 months, C-MER Eye Care Holdings Limited had revenue of 1.95B and earned 100.37M in profits. Earnings per share was 0.08.

In the last 12 months, operating cash flow was 287.00M and capital expenditures -77.52M, giving a free cash flow of 209.47M billion.

C-MER Eye Care Holdings Limited pays an annual dividend of HK$0.02, resulting in a dividend yield of 1.2%

C-MER Eye Care Holdings Limited upcoming earnings date is Sep 1, 2026, TBA (Confirmed).

C-MER Eye Care Holdings Limited as a current ratio of 1.43, with Debt / Equity ratio of 24.04%

In the past 12 months, C-MER Eye Care Holdings Limited has paid 44.35M in taxes.

C-MER Eye Care Holdings Limited EV to EBITDA ratio is 6.57, with an EV/FCF ratio of 9.61.

C-MER Eye Care Holdings Limited has HK$465.96M in cash and marketable securities with HK$426.78M in debt, giving a net cash position of HK$39.18M billion.

Gross margin is 29.58%, with operating margin of 6.76%, and net profit margin of 5.16%.

The average price target for C-MER Eye Care Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―